IMBZ1-8-g

N/A

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameIMBZ1-8-g
Drug Alias NameIMBZ18gIMBZ-18-g
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPenicillin-binding protein 3 inhibitorsBeta Lactamase inhibitors
TargetsPenicillin-binding protein 3Beta Lactamase
Therapy Area/IndicationsPyelonephritisUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Aiqixi New Drug Research Co LtdInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Aiqixi New Drug Research Co LtdHunan Sailong Pharmaceutical (Changsha) Co LtdInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsPyelonephritisUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A